About Beijing Biostar Technologies
Beijing Biostar Technologies is a company based in Beijing (China) founded in 2002.. Beijing Biostar Technologies has raised $135.23 million across 2 funding rounds from investors including Matrix Partners China, CCB International and Tianjin Venture Capital. The company has 147 employees as of December 31, 2024. Beijing Biostar Technologies operates in a competitive market with competitors including Laurus Labs, Sterling Pharma Solutions, Provepharm Life Solutions, Symbiotec and Jubilant Pharma, among others.
- Headquarter Beijing, China
- Employees 147 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
- Legal Name Beijing Biostar Pharmaceuticals Co., Ltd. Class H
-
Annual Revenue
$10.03 M (USD)5.82as on Dec 31, 2024
-
Net Profit
$-20.07 M (USD)25.61as on Dec 31, 2024
-
EBITDA
$-22.33 M (USD)24.21as on Dec 31, 2024
-
Total Equity Funding
$135.23 M (USD)
in 2 rounds
-
Latest Funding Round
$135.23 M (USD), Series E
Nov 26, 2020
-
Investors
Matrix Partners China
& 6 more
-
Employee Count
147
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Beijing Biostar Technologies
Beijing Biostar Technologies is a publicly listed company on the HKEX with ticker symbol 2563 in Hong Kong, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Funding Insights of Beijing Biostar Technologies
Beijing Biostar Technologies has successfully raised a total of $135.23M across 2 strategic funding rounds. The most recent funding activity was a Series E round of $135.23 million completed in November 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series E — $135.2M
- First Round First Round
- Investors Count 7
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2020 | Amount | Series E - Beijing Biostar Technologies | Valuation |
investors |
|
| Jan, 2019 | Amount | Series B - Beijing Biostar Technologies | Valuation | SDIC Venture Capital Management , Detong Capital |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Beijing Biostar Technologies
Beijing Biostar Technologies has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include Matrix Partners China, CCB International and Tianjin Venture Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Multiple sectors are invested in by this venture capital firm.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
Venture capital investments are managed for innovative company growth.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Beijing Biostar Technologies
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Beijing Biostar Technologies
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Beijing Biostar Technologies Comparisons
Competitors of Beijing Biostar Technologies
Beijing Biostar Technologies operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Laurus Labs, Sterling Pharma Solutions, Provepharm Life Solutions, Symbiotec and Jubilant Pharma, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Pharmaceutical and biotechnology company
|
|
| domain | founded_year | HQ Location |
Contract development, manufacturing, and analytical services for APIs are offered.
|
|
| domain | founded_year | HQ Location |
APIs and drug products are developed and valorized in pharmaceuticals.
|
|
| domain | founded_year | HQ Location |
Non-sterile steroid hormone-based APIs and intermediates are manufactured.
|
|
| domain | founded_year | HQ Location |
Pharmaceuticals, APIs, and radiopharmaceuticals are manufactured by the company.
|
|
| domain | founded_year | HQ Location |
APIs are developed and manufactured for therapeutic areas.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Beijing Biostar Technologies
Frequently Asked Questions about Beijing Biostar Technologies
When was Beijing Biostar Technologies founded?
Beijing Biostar Technologies was founded in 2002 and raised its 1st funding round 17 years after it was founded.
Where is Beijing Biostar Technologies located?
Beijing Biostar Technologies is headquartered in Beijing, China.
Who is the current CEO of Beijing Biostar Technologies?
Qiu Rongguo is the current CEO of Beijing Biostar Technologies.
Is Beijing Biostar Technologies a funded company?
Beijing Biostar Technologies is a funded company, having raised a total of $135.23M across 2 funding rounds to date.
How many employees does Beijing Biostar Technologies have?
As of Dec 31, 2024, the latest employee count at Beijing Biostar Technologies is 147.
What is the annual revenue of Beijing Biostar Technologies?
Annual revenue of Beijing Biostar Technologies is $10.03M as on Dec 31, 2024.
What does Beijing Biostar Technologies do?
Beijing Biostar Technologies was founded in 2002 in Beijing, China, within the biotechnology and pharmaceutical sector. APIs, intermediates, and biochemical reagents are developed and manufactured by the company. Development services are provided, encompassing biomedical development, technology transfer for anti-tumor small molecules, and technical consulting. Operations are centered in China, supporting pharmaceutical research and production needs.
Who are the top competitors of Beijing Biostar Technologies?
Beijing Biostar Technologies's top competitors include Laurus Labs, Symbiotec and Sterling Pharma Solutions.
Is Beijing Biostar Technologies publicly traded?
Yes, Beijing Biostar Technologies is publicly traded on HKEX under the ticker symbol 2563.
Who are Beijing Biostar Technologies's investors?
Beijing Biostar Technologies has 7 investors. Key investors include Matrix Partners China, CCB International, Tianjin Venture Capital, unknown, and SDIC Venture Capital.
What is Beijing Biostar Technologies's ticker symbol?
The ticker symbol of Beijing Biostar Technologies is 2563 on HKEX.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.